Liz Bhatt, MS, MBA

Liz Bhatt brings more than 25 years of strategy, deal-making and company-building experience across a range of biotech and pharmaceutical companies.

Liz was previously Chief Business & Strategy Officer at Applied Molecular Transport (AMT), where she oversaw corporate development, portfolio and project management, and commercial strategy. Prior to AMT, Liz was Chief Operating Officer at Achaogen where she led corporate development, alliance management and government affairs. She also had operational responsibilities overseeing technical operations and manufacturing. Prior to Achaogen, Liz spent over a decade at Gilead Sciences as VP, Corporate Development leading deals across all therapeutic areas. She also led long-term global commercial and strategic planning for Gilead’s antiviral and respiratory franchises and supported the launch of several products. Liz has also held corporate development and strategy roles at Eli Lilly and Maxygen and started her career in research at Affymax. She currently serves as an independent director on the board of eFFECTOR Therapeutics.

Liz earned a BA in chemistry from Pomona College, an MS in biomedical sciences from the University of California San Diego, and an MBA from the Kellogg School of Management at Northwestern University.